PROGENICS PHARM (NASDAQ:PGNX)

4.07

+0.08 (2.01%)

PROGENICS PHARM (NASDAQ:PGNX) Delayed :
Previous Close	$3.99	52 Week High	$10.81
Open	$3.99	52 Week Low	$3.53
Day High	$4.09	P/E	N/A
Day Low	$3.93	EPS	$-1.45
Volume	307,663
More PGNX Info: Chart SEC Filings Profile Historical Options

What is this?Friends, Peers and Foes

Ticker	# Stories	Ticker	# Stories
WYE	4	BMR	1

View All Entities

Oct 16, 2009 11:43 AM Lazard Capital Upgrades Progenics Pharmaceuticals (PGNX) to Buy
Oct 16, 2009 11:19 AM Lazard Capital Upgrades Progenics Pharmaceutical (PGNX) to Buy
Oct 14, 2009 02:19 PM Needham Cuts Progenics (PGNX) to Hold Midday
Oct 14, 2009 07:25 AM Progenics Pharma (PGNX) Regains RELISTOR Rights from Wyeth (WYE)
Sep 16, 2009 07:36 AM Progenics (PGNX) Announces Promotion of Mark R. Baker to President and Appoints Him to Board of Directors

Nov 9, 2009 08:00AM Progenics Announces Third Quarter 2009 Financial Results
Oct 29, 2009 09:29AM BioMed Realty Trust Extends Lease at Landmark With Progenics Pharmaceuticals
Oct 14, 2009 07:00AM Progenics Regains Worldwide Rights to RELISTOR Franchise

Nov 20, 2009 06:07 AM A Possible New Indication for Progenix's Relistor Could Revive Its Fortunes
Nov 16, 2009 05:50 PM Progenics: Are the Prospects That Bad?
Oct 14, 2009 01:19 PM Progenics: Investors Are Right To Be Wary
Oct 14, 2009 12:09 PM BioMed News Bytes: Progenics, Somanetics, Ziopharm, Cardium, pSivida, BioMimetic Therapeutics
Oct 5, 2009 04:48 AM Nine Companies Added to Potential Activist Targets

Nov 9, 2009 03:46PM Form 10-Q PROGENICS PHARMACEUTICAL For: Sep 30
Nov 9, 2009 11:50AM Form 8-K PROGENICS PHARMACEUTICAL For: Sep 30
Oct 19, 2009 10:58AM Form 4 PROGENICS PHARMACEUTICAL For: Oct 16 Filed by: MADDON PAUL J
Oct 16, 2009 03:04PM Form 8-K PROGENICS PHARMACEUTICAL For: Oct 09
Oct 14, 2009 10:10AM Form 8-K PROGENICS PHARMACEUTICAL For: Oct 14

No comments are currently available.